Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Failure of catalase to protect against aflatoxin B1-induced mouse lung tumorigenicity.

Guindon KA, Foley JF, Maronpot RR, Massey TE.

Toxicol Appl Pharmacol. 2008 Mar 1;227(2):179-83. Epub 2007 Oct 24.

PMID:
18155117
2.

Elevation of 8-hydroxydeoxyguanosine in DNA from isolated mouse lung cells following in vivo treatment with aflatoxin B(1).

Guindon KA, Bedard LL, Massey TE.

Toxicol Sci. 2007 Jul;98(1):57-62. Epub 2007 Mar 30.

PMID:
17400578
3.
4.

Activation of K-ras in aflatoxin B1-induced lung tumors from AC3F1 (A/J x C3H/HeJ) mice.

Donnelly PJ, Devereux TR, Foley JF, Maronpot RR, Anderson MW, Massey TE.

Carcinogenesis. 1996 Aug;17(8):1735-40.

PMID:
8761434
5.

In vivo treatment with aflatoxin B1 increases DNA oxidation, base excision repair activity and 8-oxoguanine DNA glycosylase 1 levels in mouse lung.

Guindon-Kezis KA, Mulder JE, Massey TE.

Toxicology. 2014 Jul 3;321:21-6. doi: 10.1016/j.tox.2014.03.004. Epub 2014 Mar 24.

PMID:
24675474
6.

High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.

Tam AS, Foley JF, Devereux TR, Maronpot RR, Massey TE.

Cancer Res. 1999 Aug 1;59(15):3634-40.

8.

Modulation of aflatoxin toxicity and biomarkers by lycopene in F344 rats.

Tang L, Guan H, Ding X, Wang JS.

Toxicol Appl Pharmacol. 2007 Feb 15;219(1):10-7. Epub 2006 Dec 6.

PMID:
17229449
9.

Up-regulation of nucleotide excision repair in mouse lung and liver following chronic exposure to aflatoxin B₁ and its dependence on p53 genotype.

Mulder JE, Bondy GS, Mehta R, Massey TE.

Toxicol Appl Pharmacol. 2014 Mar 1;275(2):96-103. doi: 10.1016/j.taap.2013.12.016. Epub 2013 Dec 29.

PMID:
24380836
10.

In vitro recapitulating of TP53 mutagenesis in hepatocellular carcinoma associated with dietary aflatoxin B1 exposure.

Besaratinia A, Kim SI, Hainaut P, Pfeifer GP.

Gastroenterology. 2009 Sep;137(3):1127-37, 1137.e1-5. doi: 10.1053/j.gastro.2009.06.002. Epub 2009 Jun 12.

11.

Cyclopenta[cd]pyrene-induced tumorigenicity, Ki-ras codon 12 mutations and DNA adducts in strain A/J mouse lung.

Nesnow S, Ross JA, Nelson G, Wilson K, Roop BC, Jeffers AJ, Galati AJ, Stoner GD, Sangaiah R, Gold A, et al.

Carcinogenesis. 1994 Apr;15(4):601-6. Erratum in: Carcinogenesis 1994 Jul;15(7):1471.

PMID:
8149468
12.

Natural chlorophyll inhibits aflatoxin B1-induced multi-organ carcinogenesis in the rat.

Simonich MT, Egner PA, Roebuck BD, Orner GA, Jubert C, Pereira C, Groopman JD, Kensler TW, Dashwood RH, Williams DE, Bailey GS.

Carcinogenesis. 2007 Jun;28(6):1294-302. Epub 2007 Feb 8.

PMID:
17290047
14.

Aflatoxin B1-DNA adduct formation and mutagenicity in livers of neonatal male and female B6C3F1 mice.

Woo LL, Egner PA, Belanger CL, Wattanawaraporn R, Trudel LJ, Croy RG, Groopman JD, Essigmann JM, Wogan GN, Bouhenguel JT.

Toxicol Sci. 2011 Jul;122(1):38-44. doi: 10.1093/toxsci/kfr087. Epub 2011 Apr 19. Erratum in: Toxicol Sci. 2012 Jan;125(1):326. Bouhenguel, Jason T [added].

15.

Heterozygous inactivation of TGF-beta1 increases the susceptibility to chemically induced mouse lung tumorigenesis independently of mutational activation of K-ras.

McKenna IM, Ramakrishna G, Diwan BA, Kang Y, Shiao YH, Wakefield LM, Powell DA, Anderson LM, Jakowlew SB.

Toxicol Lett. 2001 Sep 15;123(2-3):151-8.

PMID:
11641043
16.

Ras proto-oncogene activation in liver and lung tumors from B6C3F1 mice exposed chronically to methylene chloride.

Devereux TR, Foley JF, Maronpot RR, Kari F, Anderson MW.

Carcinogenesis. 1993 May;14(5):795-801.

PMID:
8504471
17.

Transgenic expression of aflatoxin aldehyde reductase (AKR7A1) modulates aflatoxin B1 metabolism but not hepatic carcinogenesis in the rat.

Roebuck BD, Johnson DN, Sutter CH, Egner PA, Scholl PF, Friesen MD, Baumgartner KJ, Ware NM, Bodreddigari S, Groopman JD, Kensler TW, Sutter TR.

Toxicol Sci. 2009 May;109(1):41-9. doi: 10.1093/toxsci/kfp003. Epub 2009 Jan 23.

18.

Dietary modulation of the biotransformation and genotoxicity of aflatoxin B(1).

Gross-Steinmeyer K, Eaton DL.

Toxicology. 2012 Sep 28;299(2-3):69-79. doi: 10.1016/j.tox.2012.05.016. Epub 2012 May 26. Review.

PMID:
22640941
19.

Tumor multiplicity, DNA adducts and K-ras mutation pattern of 5-methylchrysene in strain A/J mouse lung.

You L, Wang D, Galati AJ, Ross JA, Mass MJ, Nelson GB, Wilson KH, Amin S, Stoner JC, Nesnow S, et al.

Carcinogenesis. 1994 Nov;15(11):2613-8.

PMID:
7955114
20.

Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention.

Buetler TM, Bammler TK, Hayes JD, Eaton DL.

Cancer Res. 1996 May 15;56(10):2306-13.

Supplemental Content

Support Center